[ Price : $8.95]
FDA warns Highland, IL-based Chicago Cornea Consultants about violations in its conduct of two clinical studies with investigation...[ Price : $8.95]
FDA accepts for priority review a bluebird bio BLA for lovotibeglogene autotemcel (lovo-cel), a gene therapy for certain patients ...[ Price : $8.95]
Pieris Pharmaceuticals says its partner AstraZeneca is discontinuing a Phase 2a study of the asthma drug elarekibep.[ Price : $8.95]
An FDA complete response letter for Aldeyras ADX-2191 cites a lack of substantial evidence of effectiveness due to a lack of clini...[ Price : $8.95]
FDA grants Anumana a breakthrough device designation for its ECG-AI algorithm for detecting cardiac amyloidosis.[ Price : $8.95]
FDA commissioner Robert Califf says the agency needs to get in front of regulating large language models using ChatGPT that could ...[ Price : $8.95]
Two Brookings Institution fellows suggest three steps to address the shortage of generic sterile injectable drugs.[ Price : $8.95]
FDA grants full approval to Amgens previously accelerated-approved BLA for Blincyto (blinatumomab) for treating certain adults and...